anticancer — TargetMol Chemicals

Cat No.	Product Name	Synonyms	Targets
T60420	Anticancer agent 73		DNA/RNA Synthesis
	Anticancer agent 73 is an anticancer agent which potently targets transactivation response(TAR) RNA-binding protein 2 (TRBP) and disrupts the TRBP-Dicer interaction. Anticancer agent 73 suppresses the growth and metasta...		DNA/RNA Synthesis
T61046	Anticancer agent 43		Apoptosis
	Anticancer agent 43 is a potent anticancer agent that induces apoptosis through caspase 3, PARP1, and Bax protein-dependent pathways.Anticancer agent 43 induces DNA damage and can be used in the study of glioblastoma in ...		Apoptosis
T60852	Anticancer agent 46
	Anticancer agent 46 is a potent anti-cancer agent, showing anti-proliferative activity in cellular assays, with an IC50 of 0.986 μM against MGC803 cells.
T40330	Anticancer agent 15
	Anticancer agent 15, an anticancer agent, exerts its efficacy by elevating intracellular levels of reactive oxygen species (ROS) and inducing cell death in melanoma cancer cells through necroptosis.
T39868	Anticancer agent 11
	Anticancer agent 11 an effective broad-spectrum anticancer agent, exerts its therapeutic potential by suppressing angiogenesis and facilitating the formation of DNA cross-links.
T39501	Anticancer agent 7
	Anticancer agent 7 (Example 5) is an anti-cancer agent that exhibits potent anticancer activity against H1650 lung cancer cells, with an IC50 value of 5 μM.
T40479	Anticancer agent 13
	Anticancer agent 13 is an anticancer agent from dicarboxylic acids and amines.
T10331	Anticancer agent 3		Others
	Anticancer agent 3 (Compound 4) is a anti-cancer agent.		Others
T27998	MDK-4204	Anticancer AgentI,MDK 4204,Anticancer Agent I,MDK4204,Anticancer Agent-I
	MDK-4204, an anticancer agent, shows significant anti-cancer activity with IC50 values of 8.8 µM and 9.5 µM in PC-3 and DU-145 cells, respectively.
T62667	Anticancer agent 51
	Anticancer agent 51 (compound 3d) is a potent anticancer agent (Ki: 731.62 nM) with anticancer activity. anticancer agent 51 has potential for prostate cancer research.
T62602	Anticancer agent 49
	Anticancer agent 49 (compound 69) is a broad-spectrum anticancer agent with anti-proliferative activity. anticancer agent 48 inhibits microtubule protein aggregation and has in vivo antitumour activity. anticancer agent ...
T72502	Anticancer agent 92
	Anticancer agent 92 is an anticancer agent that is nontoxic against noncancerous cells .
T63599	Anticancer agent 54
	Anticancer agent 54 is an effective anticancer agent whose anticancer activity depends on DNA embedding and ROS generation. Anticancer agent 54 has an anti-proliferative effect by blocking the cell cycle in G0/G1 phase a...
T83091	Anticancer agent 113
	Anticancer agent 113 possesses anticancer activity [1].
T63587	Anticancer agent 45
	Anticancer agent 46 is a potent and selective anticancer agent that induces apoptosis. anticancer agent 46 exhibits cytotoxic effects in cancer cells and shows low toxicity to activated lymphocytes of human blood.
T63489	Anticancer agent 77
	Anticancer agent 77 exhibits anticancer effects and can be used extensively in synthetic and medicinal chemistry studies.
T63982	Anticancer agent 50
	Anticancer agent 50 (compound 6) is a potent modulator of the ABCB1 efflux pump with cytotoxic and anti-proliferative activity. anticancer agent 50 reduces the expression of cyclin D1 and induces p53 expression. anticanc...
T61902	Anticancer agent 69
	Anticancer agent 69 (Compound 34) is an effective selective anticancer agent with selective inhibition on human prostate cancer cell line PC3 (IC50=26 nM). Anticancer agent 69 can increase ROS level and down-regulate EGF...
T74961	Anticancer agent 84
	Anticancer Agent 84, a cancer research compound, inhibits c-MYC transcription by stabilizing the G-quadruplex (G4) structure, offering potential for cancer investigation [1].
T63522	Anticancer agent 64
	Anticancer agent 64 (compound 5m) demonstrates effective cytotoxic activity against CCRF-CEM cells, exhibiting an IC50 value of 2.4 μM. It effectively induces apoptosis in cancer cells by activating caspase 3 and 7 and c...